BACKGROUND: Aberrant DNA hypermethylation has been implicated as a component of an epigenetic mechanism that silences genes in cancers. METHODS: We performed a genome-wide search to identify differentially methylated loci between 26 tumor and adjacent non-tumor paired tissues from same lung cancer patients using restriction landmark genomic scanning (RLGS) analysis. Among 229 loci which were hypermethylated in lung tumors as compared to adjacent non-tumor tissues, solute carrier family 5, member 8 (SLC5A8) was one of the hypermethylated genes, and known as a tumor suppressor gene which is silenced by epigenetic changes in various tumors. We investigated the significance of DNA methylation in SLC5A8 expression in lung cancer cell lines, and 23 paired tumor and adjacent non-tumor lung tissues by reverse transcription-PCR (RT-PCR), quantitative methylation specific PCR (QMSP) and bisulfite modified DNA sequencing analyses. RESULTS: Reduced or lost expression of SLC5A8 was observed in 39.1% (9/23) of the tumor tissues as compared with paired adjacent non-tumor tissues. Bisulfite sequencing results of lung cancer cell lines and tissues which did not express SLC5A8 showed a densely methylated promoter region of SLC5A8. SLC5A8 was reactivated by treatment with DNA methyltransferase inhibitor, 5-Aza and/or HDAC inhibitor, trichostatin A (TSA) in lung cancer cell lines, which did not express SLC5A8. Hypermethylation was detected at the promoter region of SLC5A8 in primary lung tumor tissues as compared with adjacent non-tumor tissues (14/23, 60.9%). CONCLUSION: These results suggest that DNA methylation in the SLC5A8 promoter region may suppress the expression of SLC5A8 in lung tumor.
BACKGROUND: Aberrant DNA hypermethylation has been implicated as a component of an epigenetic mechanism that silences genes in cancers. METHODS: We performed a genome-wide search to identify differentially methylated loci between 26 tumor and adjacent non-tumor paired tissues from same lung cancerpatients using restriction landmark genomic scanning (RLGS) analysis. Among 229 loci which were hypermethylated in lung tumors as compared to adjacent non-tumor tissues, solute carrier family 5, member 8 (SLC5A8) was one of the hypermethylated genes, and known as a tumor suppressor gene which is silenced by epigenetic changes in various tumors. We investigated the significance of DNA methylation in SLC5A8 expression in lung cancer cell lines, and 23 paired tumor and adjacent non-tumor lung tissues by reverse transcription-PCR (RT-PCR), quantitative methylation specific PCR (QMSP) and bisulfite modified DNA sequencing analyses. RESULTS: Reduced or lost expression of SLC5A8 was observed in 39.1% (9/23) of the tumor tissues as compared with paired adjacent non-tumor tissues. Bisulfite sequencing results of lung cancer cell lines and tissues which did not express SLC5A8 showed a densely methylated promoter region of SLC5A8. SLC5A8 was reactivated by treatment with DNA methyltransferase inhibitor, 5-Aza and/or HDAC inhibitor, trichostatin A (TSA) in lung cancer cell lines, which did not express SLC5A8. Hypermethylation was detected at the promoter region of SLC5A8 in primary lung tumor tissues as compared with adjacent non-tumor tissues (14/23, 60.9%). CONCLUSION: These results suggest that DNA methylation in the SLC5A8 promoter region may suppress the expression of SLC5A8 in lung tumor.
Authors: Muthusamy Thangaraju; Gail Cresci; Shiro Itagaki; John Mellinger; Darren D Browning; Franklin G Berger; Puttur D Prasad; Vadivel Ganapathy Journal: J Gastrointest Surg Date: 2008-07-26 Impact factor: 3.452
Authors: Jong Y Park; James F Helm; Weipeng Zheng; Quan P Ly; Pamela J Hodul; Barbara A Centeno; Mokenge P Malafa Journal: Pancreas Date: 2008-05 Impact factor: 3.327
Authors: E Babu; S Ramachandran; V CoothanKandaswamy; S Elangovan; P D Prasad; V Ganapathy; M Thangaraju Journal: Oncogene Date: 2011-04-18 Impact factor: 9.867
Authors: Dominic J Smiraglia; Ramakrishnan Kazhiyur-Mannar; Christopher C Oakes; Yue-Zhong Wu; Ping Liang; Tahmina Ansari; Jian Su; Laura J Rush; Laura T Smith; Li Yu; Chunhui Liu; Zunyan Dai; Shih-Shih Chen; Shu-Huei Wang; Joseph Costello; Ilya Ioshikhes; David W Dawson; Jason S Hong; Michael A Teitell; Angela Szafranek; Marta Camoriano; Fei Song; Rosemary Elliott; William Held; Jacquetta M Trasler; Christoph Plass; Rephael Wenger Journal: BMC Genomics Date: 2007-11-30 Impact factor: 3.969
Authors: Adriana López-Barradas; Tania González-Cid; Norma Vázquez; Marisol Gavi-Maza; Adriana Reyes-Camacho; Laura A Velázquez-Villegas; Victoria Ramírez; Kambiz Zandi-Nejad; David B Mount; Nimbe Torres; Armando R Tovar; Michael F Romero; Gerardo Gamba; Consuelo Plata Journal: Am J Physiol Cell Physiol Date: 2016-08-03 Impact factor: 4.249
Authors: Sara Sheikholeslami; Fereidoun Azizi; Asghar Ghasemi; Abbas Alibakhshi; Hossein Parsa; Setareh Shivaee; Marjan Zarif-Yeganeh; Mehdi Hedayati; Ladan Teimoori-Toolabi Journal: Iran J Public Health Date: 2022-03 Impact factor: 1.479
Authors: Andrea Orellana-Manzano; Miguel G O'Ryan; Anne J Lagomarcino; Sergio George; Mindy S Muñoz; Nora Mamani; Carolina A Serrano; Paul R Harris; Octavio Ramilo; Asunción Mejías; Juan P Torres; Yalda Lucero; Andrew F G Quest Journal: Front Cell Infect Microbiol Date: 2016-10-10 Impact factor: 5.293